Fasting-Associated Immune-metabolic Remission of Diabetes

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

April 30, 2023

Conditions
Type 2 Diabetes MellitusObesity
Interventions
BEHAVIORAL

weight loss by very low energy diet intake which may differ in protein or carbohydrate content

The anthropometric, endocrine and metabolic status is tested before, after 7 days and after 15 kg weight loss

Trial Locations (1)

12203

Charité Campus Benjamin Franklin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT05295160 - Fasting-Associated Immune-metabolic Remission of Diabetes | Biotech Hunter | Biotech Hunter